De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
02 Apr 2024
Historique:
received: 18 11 2023
accepted: 19 03 2024
revised: 03 02 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 2 4 2024
Statut: aheadofprint

Résumé

Nine out of 19 genes encoding GABA

Identifiants

pubmed: 38565639
doi: 10.1038/s41431-024-01600-3
pii: 10.1038/s41431-024-01600-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharm Rev. 2008;60:243–60.
doi: 10.1124/pr.108.00505 pubmed: 18790874
Bryson A, Reid C, Petrou S. Fundamental neurochemistry review: GABA
doi: 10.1111/jnc.15769 pubmed: 36681890
Bencsits E, Ebert V, Tretter V, Sieghart W. A significant part of native gamma-aminobutyric AcidA receptors containing alpha4 subunits do not contain gamma or delta subunits. J Biol Chem. 1999;274:19613–6.
doi: 10.1074/jbc.274.28.19613 pubmed: 10391897
BrainRNAseq. https://www.brainrnaseq.org/ . Accessed 15 Aug 2023.
Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, et al. GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci USA. 2006;103:15230–5.
doi: 10.1073/pnas.0604304103 pubmed: 17005728 pmcid: 1578762
Brickley SG, Mody I. Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron. 2012;73:23–34.
doi: 10.1016/j.neuron.2011.12.012 pubmed: 22243744 pmcid: 3399243
Sente A, Desai R, Naydenova K, Malinauskas T, Jounaidi Y, Miehling J, et al. Differential assembly diversifies GABAA receptor structures and signaling. Nature. 2022;604:190–4.
doi: 10.1038/s41586-022-04517-3 pubmed: 35355020 pmcid: 7612593
Fan C, Gao Y, Liang G, Huang L, Wang J, Yang X, et al. Transcriptomics of Gabra4 knockout mice reveals common NMDAR pathways underlying autism, memory, and epilepsy. Mol Autism. 2020;11:13.
doi: 10.1186/s13229-020-0318-9 pubmed: 32033586 pmcid: 7007694
Roberts DS, Raol YH, Bandyopadhyay S, Lund IV, Budreck EC, Passini MA, et al. Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression. Proc Natl Acad Sci USA. 2005;102:11894–9.
doi: 10.1073/pnas.0501434102 pubmed: 16091474 pmcid: 1187961
International League Against Epilepsy Consortium on Complex Epilepsies. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018;9:5269.
doi: 10.1038/s41467-018-07524-z
Epi25 Collaborative. Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 Individuals. Am J Hum Genet. 2019;105:267–82.
doi: 10.1016/j.ajhg.2019.05.020
Hatoum AS, Morrison CL, Mitchell EC, Lam M, Benca-Bachman CE, Reineberg AE, et al. Genome-wide association study shows that executive functioning is influenced by GABAergic processes and is a neurocognitive genetic correlate of psychiatric disorders. Biol Psychiatry. 2023;93:59–70.
doi: 10.1016/j.biopsych.2022.06.034 pubmed: 36150907
Zhang K, Zhao Y, Wang Q, Jiang H, Du J, Yu S, et al. Association study of GABA system genes polymorphisms with amphetamine-induced psychotic disorder in a Han Chinese population. Neurosci Lett. 2016;622:37–44.
doi: 10.1016/j.neulet.2016.04.019 pubmed: 27080428
Maljevic S, Møller RS, Reid CA, Pérez-Palma E, Lal D, May P, et al. Spectrum of GABAA receptor variants in epilepsy. Curr Opin Neurol. 2019;32:183–90.
doi: 10.1097/WCO.0000000000000657 pubmed: 30664068
Vogel FD, Krenn M, Westphal DS, Graf E, Wagner M, Leiz S, et al. A de novo missense variant in GABRA4 alters receptor function in an epileptic and neurodevelopmental phenotype. Epilepsia. 2022;63:e35–41.
doi: 10.1111/epi.17188 pubmed: 35152403 pmcid: 9304230
Ahring PK, Liao VWY, Lin S, Absalom NL, Chebib M, Møller RS, et al. The de novo GABRA4 p.Thr300Ile variant found in a patient with early-onset intractable epilepsy and neurodevelopmental abnormalities displays gain-of-function traits. Epilepsia. 2022;63:2439–41.
doi: 10.1111/epi.17358 pubmed: 35781801
Keehan L, Haviland I, Gofin Y, Swanson LC, El Achkar CM, Schreiber J, et al. Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain. Am J Med Genet A. 2022;188:3516–24.
doi: 10.1002/ajmg.a.62940 pubmed: 35934918 pmcid: 9669137
Roller E, Ivakhno S, Lee S, Royce T, Tanner S. Canvas: versatile and scalable detection of copy number variants. Bioinformatics. 2016;32:2375–7.
doi: 10.1093/bioinformatics/btw163 pubmed: 27153601
Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Källberg M, et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2016;32:1220–2.
doi: 10.1093/bioinformatics/btv710 pubmed: 26647377
Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696–704.
doi: 10.1038/gim.2015.148 pubmed: 26633542
Hedger G, Koldsø H, Chavent M, Siebold C, Rohatgi R, Sansom MSP. Cholesterol interaction sites on the transmembrane domain of the hedgehog signal transducer and class F G protein-coupled receptor smoothened. Structure. 2019;27:549–59.e2.
doi: 10.1016/j.str.2018.11.003 pubmed: 30595453 pmcid: 6408332
Abraham MJ, Murtola T, Schulz R, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015; https://doi.org/10.1016/j.softx.2015.06.001 .
Schurr J, Coras R, Rössler K, Pieper T, Kudernatsch M, Holthausen H, et al. Mild malformation of cortical development with oligodendroglial hyperplasia in frontal lobe epilepsy: a new clinico-pathological entity. Brain Pathol. 2017;27:26–35.
doi: 10.1111/bpa.12347 pubmed: 26748554
Wang MD, Rahman M, Johansson IM, Bäckström T. Agonist function of the recombinant alpha 4 beta 3 delta GABAA receptor is dependent on the human and rat variants of the alpha 4-subunit. Clin Exp Pharm Physiol. 2010;37:662–9.
doi: 10.1111/j.1440-1681.2010.05374.x
Hernandez CC, Macdonald RL. A structural look at GABAA receptor mutations linked to epilepsy syndromes. Brain Res. 2019;1714:234–47.
doi: 10.1016/j.brainres.2019.03.004 pubmed: 30851244
Krenn M, Wagner M, Hotzy C, Graf E, Weber S, Brunet T, et al. Diagnostic exome sequencing in non-acquired focal epilepsies highlights a major role of GATOR1 complex genes. J Med Genet. 2020;57:624–33.
doi: 10.1136/jmedgenet-2019-106658 pubmed: 32086284
Samocha KE, Kosmicki JA, Karczewski KJ, O’Donnel-Luria AH, Pierce-Hoffman E, MacArthur DG, et al. Regional missense constraint improves variant deleteriousness prediction. bioRxiv. Preprint posted online June 12, 2017. https://doi.org/10.1101/148353 .
Stosser MB, Lindy AS, Butler E, Retterer K, Piccirillo-Stosser CM, Richard G, et al. High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders. Genet Med. 2018;20:403–10.
doi: 10.1038/gim.2017.114 pubmed: 28837158
Gennaro E, Santorelli FM, Bertini E, Buti D, Gaggero R, Gobbi G, et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun. 2006;341:489–93.
doi: 10.1016/j.bbrc.2005.12.209 pubmed: 16430863
Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728–39.
doi: 10.1038/nrn920 pubmed: 12209121
Kodera H, Ohba C, Kato M, Maeda T, Araki K, Tajima D, et al. De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia. 2016;57:566–73.
doi: 10.1111/epi.13344 pubmed: 26918889
Bosch DG, Boonstra FN, de Leeuw N, Pfundt R, Nillese WM, de Ligt J, et al. Novel genetic causes for cerebral visual impairment. Eur J Hum Genet. 2016;24:660–5.
doi: 10.1038/ejhg.2015.186 pubmed: 26350515
Heyne HO, Singh T, Stamberger H, Abou Jamra R, Caglayan H, Craiu D, et al. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet. 2018;50:1048–53.
doi: 10.1038/s41588-018-0143-7 pubmed: 29942082
El Achkar CM, Harrer M, Smith L, Kelly M, Iqbal S, Maljevic S, et al. Characterization of the GABRB2-associated neurodevelopmental disorders. Ann Neurol. 2021;89:573–86.
doi: 10.1002/ana.25985 pubmed: 33325057
Møller RS, Wuttke TV, Helbig I, Marini C, Johannesen KM, Brilstra EH, et al. Mutations in GABRB3: from febrile seizures to epileptic encephalopathies. Neurology. 2017;88:483–92.
doi: 10.1212/WNL.0000000000003565 pubmed: 28053010 pmcid: 5278942
Shen D, Hernandez CC, Shen W, Hu N, Poduri A, Shiedley B, et al. De novo GABRG2 mutations associated with epileptic encephalopathies. Brain. 2017;140:49–67.
doi: 10.1093/brain/aww272 pubmed: 27864268

Auteurs

Samin A Sajan (SA)

Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Ralph Gradisch (R)

Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.

Florian D Vogel (FD)

Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, Vienna, Austria.

Alison J Coffey (AJ)

lllumina Clinical Services Laboratory, Illumina Inc., San Diego, CA, USA.

Daria Salyakina (D)

Personalized Medicine and Health Outcomes Research, Nicklaus Children's Hospital, Miami, FL, USA.

Diana Soler (D)

Personalized Medicine and Health Outcomes Research, Nicklaus Children's Hospital, Miami, FL, USA.

Parul Jayakar (P)

Division of Genetics and Metabolism, Nicklaus Children's Hospital, Miami, FL, USA.

Anuj Jayakar (A)

Department of Neurology, Division of Epilepsy, Nicklaus Children's Hospital, Miami, FL, USA.

Simona E Bianconi (SE)

Kaiser Permanente, San Diego, CA, USA.

Annina H Cooper (AH)

Kaiser Permanente, San Diego, CA, USA.

Shuxi Liu (S)

GeneDx, Gaithersburg, MD, USA.

Nancy William (N)

Mayo Clinic, Rochester, MN, USA.

Ira Benkel-Herrenbrück (I)

Kinderneurologisches Zentrum, Sana Kliniken Düsseldorf, Düsseldorf, Germany.

Robert Maiwald (R)

Medizinisches Versorgungszentrum für Gerinnungsdiagnostik und Medizinische Genetik Köln, Köln, Germany.

Corina Heller (C)

Zentrum für Humangenetik, Tübingen, Germany.

Saskia Biskup (S)

Zentrum für Humangenetik, Tübingen, Germany.
Center for Genomics and Transcriptomics (CeGaT), Tübingen, Germany.

Steffen Leiz (S)

Division of Neuropediatrics, Klinikum Dritter Orden, Munich, Germany.

Dominik S Westphal (DS)

Institute of Human Genetics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Department of Internal Medicine I, School of Medicine & Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Matias Wagner (M)

Institute of Human Genetics, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Amy Clarke (A)

Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

Thomas Stockner (T)

Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

Margot Ernst (M)

Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, Vienna, Austria.

Akanchha Kesari (A)

lllumina Clinical Services Laboratory, Illumina Inc., San Diego, CA, USA.

Martin Krenn (M)

Department of Neurology, Medical University of Vienna, Vienna, Austria. martin.krenn@meduniwien.ac.at.
Comprehensive Center for Clinical Neurosciences & Mental Health, Medical University of Vienna, Vienna, Austria. martin.krenn@meduniwien.ac.at.

Classifications MeSH